Literature DB >> 20805895

Augmentation and combination strategies to treat the residual symptoms of major depressive disorder.

Maurizio Fava1, Steven D Targum.   

Abstract

Entities:  

Year:  2007        PMID： 20805895      PMCID： PMC2922343     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


× No keyword cloud information.
  8 in total

Review 1.  Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.

Authors:  Maurizio Fava; A John Rush
Journal:  Psychother Psychosom       Date:  2006       Impact factor: 17.659

2.  A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.

Authors:  Andrew A Nierenberg; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Michael E Thase; Patrick J McGrath; Jonathan E Alpert; Diane Warden; James F Luther; George Niederehe; Barry Lebowitz; Kathy Shores-Wilson; A John Rush
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

3.  Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

Authors:  Patrick J McGrath; Jonathan W Stewart; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Michael E Thase; Lori Davis; Melanie M Biggs; Kathy Shores-Wilson; James F Luther; George Niederehe; Diane Warden; A John Rush
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

4.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

5.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

6.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

7.  Residual symptoms after partial remission: an important outcome in depression.

Authors:  E S Paykel; R Ramana; Z Cooper; H Hayhurst; J Kerr; A Barocka
Journal:  Psychol Med       Date:  1995-11       Impact factor: 7.723

8.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Authors:  Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242
  8 in total
  1 in total

Review 1.  Identification and treatment of antidepressant tachyphylaxis.

Authors:  Steven D Targum
Journal:  Innov Clin Neurosci       Date:  2014-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.